Skip to content

Public FDA record

Z-0810-2021: EXOGEN Ultrasound Coupling Gel

Recall record Z-0810-2021 for Bioventus, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0810-2021
Company in FDA record
Bioventus, LLC
FDA record creation date
Jan 9, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product may contain white particulates that are microbial in nature.

Source facts

Action
Device Recall Notice 3010203571-12/14/20-001-R was sent to customers beginning 12/17/2020. Customers were instructed to dispose of the product and verify disposal lot and quantity.
Initiated
2020-12-17
Root cause
Nonconforming Material/Component
Terminated
2024-08-07
Distribution
United States (Nationwide), Australia, Austria, Belgium, Canada, Cyprus, Denmark, France, Germany, Hong Kong, Ireland, Italy, Japan, Netherlands, Norway, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
Recall number
Z-0810-2021
Recall status
Terminated
CDRH record ID
185027
FDA record created
2021-01-09
Recall event number
87002

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗